Pharmacokinetics of rFVIIIFc at Two Vial Strengths

NCT02083965 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

19

Enrollment

INDUSTRY

Sponsor class

Conditions

Severe Hemophilia A

Interventions

BIOLOGICAL: rFVIIIFc

Sponsor

Bioverativ Therapeutics Inc.